Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1409639.RA8N0Rsu6fg5DYuFQiuscTdx5qMb7U9jlefh3JoUcHeQ8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1409639.RA8N0Rsu6fg5DYuFQiuscTdx5qMb7U9jlefh3JoUcHeQ8130_assertion type Assertion NP1409639.RA8N0Rsu6fg5DYuFQiuscTdx5qMb7U9jlefh3JoUcHeQ8130_head.
- NP1409639.RA8N0Rsu6fg5DYuFQiuscTdx5qMb7U9jlefh3JoUcHeQ8130_assertion wasGeneratedBy ECO_0000203 NP1409639.RA8N0Rsu6fg5DYuFQiuscTdx5qMb7U9jlefh3JoUcHeQ8130_provenance.
- NP1409639.RA8N0Rsu6fg5DYuFQiuscTdx5qMb7U9jlefh3JoUcHeQ8130_assertion wasDerivedFrom befree-2016 NP1409639.RA8N0Rsu6fg5DYuFQiuscTdx5qMb7U9jlefh3JoUcHeQ8130_provenance.
- NP1409639.RA8N0Rsu6fg5DYuFQiuscTdx5qMb7U9jlefh3JoUcHeQ8130_assertion SIO_000772 9829540 NP1409639.RA8N0Rsu6fg5DYuFQiuscTdx5qMb7U9jlefh3JoUcHeQ8130_provenance.
- NP1409639.RA8N0Rsu6fg5DYuFQiuscTdx5qMb7U9jlefh3JoUcHeQ8130_assertion evidence source_evidence_literature NP1409639.RA8N0Rsu6fg5DYuFQiuscTdx5qMb7U9jlefh3JoUcHeQ8130_provenance.
- NP1409639.RA8N0Rsu6fg5DYuFQiuscTdx5qMb7U9jlefh3JoUcHeQ8130_assertion description "[This Phase I study, Ribozyme Gene Therapy of HIV-1 Infection (UCSD HSC #971072, FDA BB-IND 6405), is a prospective, open-label trial of infusion of autologous gene-altered cells into asymptomatic HIV-1 seropositive individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1409639.RA8N0Rsu6fg5DYuFQiuscTdx5qMb7U9jlefh3JoUcHeQ8130_provenance.